Japan approves remdesivir for COVID-19 treatment in expedited review
TOKYO, May 7 Kyodo - The Japanese government approved Thursday the use of the anti-viral drug remdesivir for novel coronavirus patients in an expedited review as Japan, like other countries, scramb